Exploring Predictive Genetic Testing Practices Across Adult‐Onset Neurodegenerative Disorders
Journal of Genetic Counseling · 2026-12 · 35 (6)
DOI: 10.1002/jgc4.70305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 19.11.2026. Verfasst von Cal Burns und 3 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
A predictive genetic testing protocol for Huntington disease (HD) has been published and utilized since 1989. The current guideline recommends an intake call, pre‐test genetic counseling, neurological examination, mental health assessment, results disclosure, and post‐test follow up. Predictive testing is now available for other common adult‐onset neurodegenerative disorders (AOND), including Alzheimer's disease, amyotrophic lateral sclerosis, spinocerebellar ataxia, frontotemporal dementia, Parkinson's disease, prion disease, and CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), yet similar protocols for most of these conditions have not been developed. It is hypothesized that the HD protocol is guiding predictive testing across AONDs, but this has not been formally evaluated. This exploratory, cross‐sectional study surveyed genetic counselors (GCs) regarding their predictive testing practices. A total of 70 responses were received; 66 were included in demographic and other characteristic analysis, and 59 were included in practice descriptive analysis. GCs reported an average of 1.89 predictive cases per month and primarily operated within a neurology clinic (52/66, 79%). A total of 215 predictive testing practices were collected from the 59 respondents. Pre‐test GC appointments (99%, n = 213) and a results disclosure session (100%, n = 215) were consistently incorporated in current practices. Over half of respondents utilized a mental health assessment (63%, n = 136) and structured follow‐up after results are disclosed (58%, n = 124). Less than half of respondents utilized an intake call (48%, n = 104) and neurological examination (38%, n = 81). This study found that a vast majority of pre‐test GC appointments were documented in the electronic medical record (207/213, 97%) and billed using insurance (164/213, 77%). GCs were reported as the most frequent healthcare professional involved in the assessment of mental health (118/136, 97%). Overall, these findings suggest that GCs are adapting the current HD predictive testing protocol similarly across AONDs. These findings provide insight into the current practices of predictive testing for AONDs in the absence of formal condition‐specific guidelines.
Zitieren
APA
Burns, C., Bergner, A. L., Mulhern, M., & Harrington, E. (2026). Exploring Predictive Genetic Testing Practices Across Adult‐Onset Neurodegenerative Disorders. Journal of Genetic Counseling, 35(6). https://doi.org/10.1002/jgc4.70305
Vancouver
Burns C, Bergner AL, Mulhern M, Harrington E. Exploring Predictive Genetic Testing Practices Across Adult‐Onset Neurodegenerative Disorders. Journal of Genetic Counseling. 2026;35(6). doi:10.1002/jgc4.70305
BibTeX
@article{Burns2026,
author = {Burns, Cal and Bergner, Amanda L. and Mulhern, Maureen and Harrington, Elizabeth},
title = {Exploring Predictive Genetic Testing Practices Across Adult‐Onset Neurodegenerative Disorders},
journal = {Journal of Genetic Counseling},
year = {2026},
volume = {35},
number = {6},
doi = {10.1002/jgc4.70305}
}
EUVIMED